Advanced Search

 

Study ID Status Title Patient Level Data
205035 Completed A randomized, single-center, crossover, comparative bioavailability and adhesion performance study, comparing single administrations of a new scopolamine transdermal delivery system formulation to the currently established reference transdermal delivery system in healthy adult participants.
205037 Active, not recruiting A single-centre, randomized, double-blind, dose-ascending, placebo-controlled study to evaluate the safety, tolerability, and pharmacokinetics of oral TID doses (one day) of GSK2982772 in Japanese healthy male subjects
205045 Completed A clinical study investigating the Gingivitis Efficacy of a Stannous Fluoride Dentifrice
205049 Recruiting Prevalence, strain circulation and disease burden of seasonal Influenza A and B in Panama, selected countries of Central America and the Caribbean from the Year 2010 to 2015
205050 Terminated Study 205050: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Investigate the Efficacy and Safety of Mepolizumab Administered Subcutaneously in Subjects with Moderate to Severe Atopic Dermatitis
205051 Completed A Study to Investigate the Antimicrobial Activity of two Test Toothpastes in a Plaque Glycolysis and Regrowth Model
205052 Completed Drug utilisation study of new users of fluticasone furoate / vilanterol (FF/VI) in the primary care setting: UK Clinical Practice Research Datalink (CPRD) study
205053 Recruiting Study to assess inhaled drug distribution in the distal lung and interstitium using cryobiopsy samples from subjects with suspected Interstitial Lung Disease undergoing cryobiopsy for clinical reasons
205064 Completed PGx7648: Exploratory PGx analysis of ADRB2 Thr164Ile on risk of severe asthma exacerbation in study 201722
205065 Not yet recruiting Evaluation Of Use of Belimumab in Clinical Practice Settings (OBSErve)- Observations from Brazil
205067 Completed A Clinical Study Evaluating the Consumer Perception of an Experimental Mouthwash Formulation After a Single Use
205072 Completed A Clinical Study Investigating the Efficacy of an Occluding Dentifrice in Providing Relief from Dentinal Hypersensitivity
205076 Withdrawn 205076: A Phase II, multicenter, randomized, double-blind (sponsor-unblind), placebo- controlled, parallel group trial to evaluate the efficacy and safety of sirukumab in subjects with severe, poorly controlled asthma
205081 Active, not recruiting Efficacy, immunogenicity and safety study of GSK Biologicals’ candidate malaria vaccine (SB257049) evaluating various dose schedules in a sporozoite challenge model in healthy malaria-naïve adults
205084 Completed A Clinical Study Investigating the Efficacy of an Occluding Dentifrice in Providing Relief from Dentinal Hypersensitivity
205085 Completed A physiological profile of recovery from mechanical, metabolic, and mixed exercise stressors
205086 Completed Real world survey to describe the characteristics, experience and treatment satisfaction for Systemic Lupus Erythematosus / Lupus Nephritis patients within the 2015 Adelphi Lupus DSP
205162 Completed PGX7646: Evaluation of relationships between UGT1A1 and UGT1A9 genotypes and cabotegravir pharmacokinetics and tolerability
205163 Recruiting An open label, multi-centre, post marketing surveillance (PMS) to monitor the safety and effectiveness of INCRUSE administered in Korean subjects with chronic obstructive pulmonary disease (COPD) in usual practice
205165 Withdrawn A Phase III, 4-week, randomized, double-blind study to compare ‘closed’ triple therapy (FF/UMEC/VI), 'open' triple therapy (FF/VI + UMEC) and dual therapy (FF/VI) in subjects with chronic obstructive pulmonary disease (COPD)
205173 Not yet recruiting Cross-sectional survey to evaluate quality-of-life impact of GLP-1–related nausea and vomiting in T2DM patients
205180 Completed A Phase IIa, Double-Blind, Mechanistic Study of GSK3196165 in Combination with Methotrexate Therapy in Subjects with Active Rheumatoid Arthritis Despite Treatment with DMARDs
205181 Completed A Phase I, 14 Day, Randomized, Double-Blind (sponsor unblinded), Placebo-Controlled, Repeat Dose, Ascending Cohort Study to Evaluate the Safety, Tolerability Pharmacokinetics, Gastrointestinal Transit Time and Pharmacodynamic biomarkers of GSK3179106, a REarranged during Transfection (RET) Growth Factor Receptor Tyrosine Kinase Inhibitor, in Normal Healthy Volunteers
205184 Recruiting A single-centre, randomized, double-blind (sponsor-unblinded), placebo-controlled study to evaluate the safety, tolerability and pharmacokinetics of GSK2982772 in repeat oral doses in healthy subjects
205194 Completed Adapt and Perform: the Impact of Increased Dietary Protein on the Metabolic Adaptation to Endurance Running and Subsequent Endurance Performance

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.